Sandhya Pola

Sandhya Pola is a Senior Scientist in Bioanalytical ADME at Eli Lilly and Company, having previously held positions at Intellia Therapeutics, Omeros Corporation, Curia, AMRI, and Cyprotex. Sandhya has a solid background as a DMPK Scientist with extensive experience in bioanalytical methodologies, regulatory compliance, and drug metabolism studies in both in-vivo and in-vitro settings. They hold a Master's degree in Analytical Chemistry from Texas A&M University and are a Certara Certified NCA Analyst proficient in LC-MS and various assay techniques.